Symrise announced a cash offer to the shareholders of Probi, a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. WHO: Probi is a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. Founded on science, and together with customers and research partners, Probi is striving towards a future in which as many people as possible can take control of their gut microbiome—so that they can live better lives for longer. Since its founding in 1991 at Sweden’s Lund University, Probi has expanded its operations to more than 40 markets, and holds almost 400 patents globally.Symrise is a global supplier of fragrances, flavors, food, nutrition, and cosmetic ingredients, listed on the Frankfurt Stock Exchange. Headquartered in Holzminden, Germany, the group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States, and Latin America.IN THEIR OWN WORDS: Jean-Yves Parisot, CEO of Symrise, said, “We are excited to present this opportunity for shareholders of Probi to realize their investment at an attractive valuation. Symrise has been a long-term shareholder in Probi and has acted with a long-term perspective in the best interests of the Company, its employees and shareholders. Today's offer to Probi’s shareholders reflects Symrise's conviction that Probi would see its prospects enhanced in a private environment. Symrise’s offer comes at an attractive premium and provides Probi’s shareholders with the opportunity to receive their consideration in cash in a timely manner.